Table 3.

Soft tissue outcomes. Mean difference (in mm), ± SD and 95% Confidence Interval of the difference (upper 95% CI; lower 95% CI) of the measurements of the five midfacial regions on DM 1 for immediate effects and on DM 2 for overall effects. To indicate the 1-year follow-up period T1–T2 was calculated. T-test was used for intergroup comparison between T0–T1 and T1–T2. Level of significance was set at 0.05

	T0–T1 (DM1)	T1–T2 (DM1-DM2)	T0–T2 (DM2)
Nose (mean 1)	0.30 ± 0.55 (0.23; 0.37)*	0.00 ± 0.21 (−0.08; 0.08)	0.30 ± 0.73 (0.20; 0.40)*
Left of philtrum (mean 2)	0.93 ± 0.42 (0.71; 1.16)*	−0.33 ± 0.62 (−0.10; −0.57)*	0.60 ± 0.57 (0.29; 0.91)*
Philtrum (mean 3)	0.21 ± 0.59 (−0.03; 0.45)	−0.59 ± 0.72 (−0.32; −0.87)*	−0.38 ± 0.76 (−0.77; 0.01)
Right of philtrum (mean 4)	0.74 ± 0.42 (0.50; 0.99)*	−0.34 ± 0.96 (0.03; −0.70)	0.40 ± 0.58 (0.00; 0.80)*
Upper lip TUBERCLES (mean 5)	0.81 ± 0.87 (0.44; 1.18)*	−0.09 ± 1.18 (0.35; −0.54)	0.71 ± 1.06 (0.20; 1.23)*

DM: distance map; *: p < 0.05